U.S. markets open in 4 hours 18 minutes

Sierra Oncology, Inc. (SRRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.40-0.06 (-0.33%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
204.43M178.39M111.99M125.79M102.09M
Enterprise Value 3
100.76M69.79M-10.80M-7.27M-44.88M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
615.691.48kN/AN/AN/A
Price/Book (mrq)
2.091.690.960.971.18
Enterprise Value/Revenue 3
335.85348.93-107.98N/AN/A
Enterprise Value/EBITDA 7
-1.56-3.910.750.442.79

Trading Information

Stock Price History

Beta (5Y Monthly) 1.08
52-Week Change 366.76%
S&P500 52-Week Change 343.49%
52 Week High 320.43
52 Week Low 310.02
50-Day Moving Average 316.99
200-Day Moving Average 314.95

Share Statistics

Avg Vol (3 month) 335.29k
Avg Vol (10 day) 39.24k
Shares Outstanding 511.63M
Implied Shares Outstanding 6N/A
Float 3.65M
% Held by Insiders 16.35%
% Held by Institutions 185.12%
Shares Short (Mar 30, 2021) 424.23k
Short Ratio (Mar 30, 2021) 40.36
Short % of Float (Mar 30, 2021) 40.55%
Short % of Shares Outstanding (Mar 30, 2021) 40.21%
Shares Short (prior month Feb 25, 2021) 48.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 22, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Jan 22, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-21,313.67%

Management Effectiveness

Return on Assets (ttm)-30.88%
Return on Equity (ttm)-87.79%

Income Statement

Revenue (ttm)300k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-44.82M
EBITDA -63.7M
Net Income Avi to Common (ttm)-80.9M
Diluted EPS (ttm)-7.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.06M
Total Cash Per Share (mrq)8.95
Total Debt (mrq)382k
Total Debt/Equity (mrq)0.39
Current Ratio (mrq)11.38
Book Value Per Share (mrq)8.80

Cash Flow Statement

Operating Cash Flow (ttm)-52.37M
Levered Free Cash Flow (ttm)-85.59M